Loading...
TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy
BACKGROUND: Before the advent of neoadjuvant chemotherapy, radiotherapy and surgery alone were associated with a high risk of uncontrolled locoregional relapses in locally advanced breast cancer (LABC). MATERIAL AND METHODS: In the 1990s we initiated two neoadjuvant protocols, where patients with LA...
Na minha lista:
Udgivet i: | Acta Oncol |
---|---|
Main Authors: | , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Informa Healthcare
2014
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4245178/ https://ncbi.nlm.nih.gov/pubmed/24909504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/0284186X.2014.922215 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|